MDWD

MediWound Ltd. is an Israeli biopharmaceutical company specializing in the development, manufacturing, and commercialization of enzymatic therapeutics for severe burns, chronic wounds, and other hard-to-heal wounds. The company markets NexoBrid for burn wound debridement and EscharEx for chronic wound treatment.